{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:09:16Z","timestamp":1790856556340,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,3,14]],"date-time":"2016-03-14T00:00:00Z","timestamp":1457913600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Biotechnol"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1038\/nbt.3506","type":"journal-article","created":{"date-parts":[[2016,3,14]],"date-time":"2016-03-14T11:39:38Z","timestamp":1457955578000},"page":"414-418","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":255,"title":["An injectable nanoparticle generator enhances delivery of cancer therapeutics"],"prefix":"10.1038","volume":"34","author":[{"given":"Rong","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guodong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8374-4352","authenticated-orcid":false,"given":"Junhua","family":"Mai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyong","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Segura-Ibarra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suhong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianliang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoran","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhua","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingxiao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7675-3461","authenticated-orcid":false,"given":"Eugene","family":"Koay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe E","family":"Ensor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elvin","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuewu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haifa","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,3,14]]},"reference":[{"key":"BFnbt3506_CR1","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/nbt.3330","volume":"33","author":"E Blanco","year":"2015","unstructured":"Blanco, E., Shen, H. & Ferrari, M. Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nat. Biotechnol. 33, 941\u2013951 (2015).","journal-title":"Nat. Biotechnol."},{"key":"BFnbt3506_CR2","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.tibtech.2009.12.007","volume":"28","author":"M Ferrari","year":"2010","unstructured":"Ferrari, M. Frontiers in cancer nanomedicine: directing mass transport through biological barriers. Trends Biotechnol. 28, 181\u2013188 (2010).","journal-title":"Trends Biotechnol."},{"key":"BFnbt3506_CR3","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/nrc3092","volume":"11","author":"F Michor","year":"2011","unstructured":"Michor, F., Liphardt, J., Ferrari, M. & Widom, J. What does physics have to do with cancer? Nat. Rev. Cancer 11, 657\u2013670 (2011).","journal-title":"Nat. Rev. Cancer"},{"key":"BFnbt3506_CR4","first-page":"7319","volume":"34","author":"MY Lien","year":"2014","unstructured":"Lien, M.Y. et al. Safety and efficacy of pegylated liposomal doxorubicin-based adjuvant chemotherapy in patients with stage I-III triple-negative breast cancer. Anticancer Res. 34, 7319\u20137326 (2014).","journal-title":"Anticancer Res."},{"key":"BFnbt3506_CR5","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.ctrv.2008.01.008","volume":"34","author":"S Verma","year":"2008","unstructured":"Verma, S., Dent, S., Chow, B.J., Rayson, D. & Safra, T. Metastatic breast cancer: the role of pegylated liposomal doxorubicin after conventional anthracyclines. Cancer Treat. Rev. 34, 391\u2013406 (2008).","journal-title":"Cancer Treat. Rev."},{"key":"BFnbt3506_CR6","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0169-409X(97)00131-2","volume":"32","author":"HM Patel","year":"1998","unstructured":"Patel, H.M. & Moghimi, S.M. Serum-mediated recognition of liposomes by phagocytic cells of the reticuloendothelial system\u2014the concept of tissue specificity. Adv. Drug Deliv. Rev. 32, 45\u201360 (1998).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"BFnbt3506_CR7","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.jconrel.2009.10.014","volume":"141","author":"P Decuzzi","year":"2010","unstructured":"Decuzzi, P. et al. Size and shape effects in the biodistribution of intravascularly injected particles. J. Control. Release 141, 320\u2013327 (2010).","journal-title":"J. Control. Release"},{"key":"BFnbt3506_CR8","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1021\/ja309812z","volume":"135","author":"A Lesniak","year":"2013","unstructured":"Lesniak, A. et al. Nanoparticle adhesion to the cell membrane and its effect on nanoparticle uptake efficiency. J. Am. Chem. Soc. 135, 1438\u20131444 (2013).","journal-title":"J. Am. Chem. Soc."},{"key":"BFnbt3506_CR9","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/nrc706","volume":"2","author":"MM Gottesman","year":"2002","unstructured":"Gottesman, M.M., Fojo, T. & Bates, S.E. Multidrug resistance in cancer: role of ATP-dependent transporters. Nat. Rev. Cancer 2, 48\u201358 (2002).","journal-title":"Nat. Rev. Cancer"},{"key":"BFnbt3506_CR10","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/nnano.2007.387","volume":"2","author":"D Peer","year":"2007","unstructured":"Peer, D. et al. Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotechnol. 2, 751\u2013760 (2007).","journal-title":"Nat. Nanotechnol."},{"key":"BFnbt3506_CR11","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/nnano.2008.34","volume":"3","author":"E Tasciotti","year":"2008","unstructured":"Tasciotti, E. et al. Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications. Nat. Nanotechnol. 3, 151\u2013157 (2008).","journal-title":"Nat. Nanotechnol."},{"key":"BFnbt3506_CR12","doi-asserted-by":"publisher","first-page":"4640","DOI":"10.1002\/anie.200250653","volume":"42","author":"Y Bae","year":"2003","unstructured":"Bae, Y., Fukushima, S., Harada, A. & Kataoka, K. Design of environment-sensitive supramolecular assemblies for intracellular drug delivery: polymeric micelles that are responsive to intracellular pH change. Angew. Chem. Int. Edn Engl. 42, 4640\u20134643 (2003).","journal-title":"Angew. Chem. Int. Edn Engl."},{"key":"BFnbt3506_CR13","first-page":"1","volume":"17","author":"N Demaurex","year":"2002","unstructured":"Demaurex, N. pH Homeostasis of cellular organelles. News Physiol. Sci. 17, 1\u20135 (2002).","journal-title":"News Physiol. Sci."},{"key":"BFnbt3506_CR14","doi-asserted-by":"publisher","first-page":"17627","DOI":"10.1073\/pnas.1211714109","volume":"109","author":"S Padilla-Parra","year":"2012","unstructured":"Padilla-Parra, S. et al. Quantitative imaging of endosome acidification and single retrovirus fusion with distinct pools of early endosomes. Proc. Natl. Acad. Sci. USA 109, 17627\u201317632 (2012).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnbt3506_CR15","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s11095-008-9697-x","volume":"26","author":"P Decuzzi","year":"2009","unstructured":"Decuzzi, P., Pasqualini, R., Arap, W. & Ferrari, M. Intravascular delivery of particulate systems: does geometry really matter? Pharm. Res. 26, 235\u2013243 (2009).","journal-title":"Pharm. Res."},{"key":"BFnbt3506_CR16","doi-asserted-by":"publisher","first-page":"4225","DOI":"10.1002\/adfm.201200869","volume":"22","author":"B Godin","year":"2012","unstructured":"Godin, B. et al. Discoidal porous silicon particles: fabrication and biodistribution in breast cancer bearing mice. Adv. Funct. Mater. 22, 4225\u20134235 (2012).","journal-title":"Adv. Funct. Mater."},{"key":"BFnbt3506_CR17","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.jconrel.2011.10.021","volume":"158","author":"AL van de Ven","year":"2012","unstructured":"van de Ven, A.L. et al. Rapid tumoritropic accumulation of systemically injected plateloid particles and their biodistribution. J. Control. Release 158, 148\u2013155 (2012).","journal-title":"J. Control. Release"},{"key":"BFnbt3506_CR18","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/S0167-8140(84)80077-8","volume":"2","author":"JL Wike-Hooley","year":"1984","unstructured":"Wike-Hooley, J.L., Haveman, J. & Reinhold, H.S. The relevance of tumour pH to the treatment of malignant disease. Radiother. Oncol. 2, 343\u2013366 (1984).","journal-title":"Radiother. Oncol."},{"key":"BFnbt3506_CR19","doi-asserted-by":"publisher","first-page":"710","DOI":"10.7326\/0003-4819-91-5-710","volume":"91","author":"DD Von Hoff","year":"1979","unstructured":"Von Hoff, D.D. et al. Risk factors for doxorubicin-induced congestive heart failure. Ann. Intern. Med. 91, 710\u2013717 (1979).","journal-title":"Ann. Intern. Med."},{"key":"BFnbt3506_CR20","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1038\/nm.2919","volume":"18","author":"S Zhang","year":"2012","unstructured":"Zhang, S. et al. Identification of the molecular basis of doxorubicin-induced cardiotoxicity. Nat. Med. 18, 1639\u20131642 (2012).","journal-title":"Nat. Med."},{"issue":"suppl. 5","key":"BFnbt3506_CR21","doi-asserted-by":"publisher","first-page":"v3","DOI":"10.1093\/annonc\/mdm172","volume":"18","author":"T Fojo","year":"2007","unstructured":"Fojo, T. & Menefee, M. Mechanisms of multidrug resistance: the potential role of microtubule-stabilizing agents. Ann. Oncol. 18 (suppl. 5), v3\u2013v8 (2007).","journal-title":"Ann. Oncol."},{"key":"BFnbt3506_CR22","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0065-2571(00)00013-3","volume":"41","author":"H Maeda","year":"2001","unstructured":"Maeda, H. The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. Adv. Enzyme Regul. 41, 189\u2013207 (2001).","journal-title":"Adv. Enzyme Regul."},{"key":"BFnbt3506_CR23","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.addr.2015.01.002","volume":"91","author":"H Maeda","year":"2015","unstructured":"Maeda, H. Toward a full understanding of the EPR effect in primary and metastatic tumors as well as issues related to its heterogeneity. Adv. Drug Deliv. Rev. 91, 3\u20136 (2015).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"BFnbt3506_CR24","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1200\/JCO.2007.14.4147","volume":"26","author":"C Liedtke","year":"2008","unstructured":"Liedtke, C. et al. Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer. J. Clin. Oncol. 26, 1275\u20131281 (2008).","journal-title":"J. Clin. Oncol."},{"key":"BFnbt3506_CR25","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1002\/adhm.201100005","volume":"1","author":"H Shen","year":"2012","unstructured":"Shen, H. et al. Cooperative, nanoparticle-enabled thermal therapy of breast cancer. Adv. Healthc. Mater. 1, 84\u201389 (2012).","journal-title":"Adv. Healthc. Mater."},{"key":"BFnbt3506_CR26","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jchromb.2012.01.025","volume":"887\u2013888","author":"K Alhareth","year":"2012","unstructured":"Alhareth, K., Vauthier, C., Gueutin, C., Ponchel, G. & Moussa, F. HPLC quantification of doxorubicin in plasma and tissues of rats treated with doxorubicin loaded poly(alkylcyanoacrylate) nanoparticles. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 887\u2013888, 128\u2013132 (2012).","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"BFnbt3506_CR27","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1158\/0008-5472.CAN-08-3559","volume":"69","author":"DR Hurst","year":"2009","unstructured":"Hurst, D.R. et al. Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis. Cancer Res. 69, 1279\u20131283 (2009).","journal-title":"Cancer Res."},{"key":"BFnbt3506_CR28","doi-asserted-by":"publisher","first-page":"9385","DOI":"10.1073\/pnas.0900108106","volume":"106","author":"X Lu","year":"2009","unstructured":"Lu, X. & Kang, Y. Efficient acquisition of dual metastasis organotropism to bone and lung through stable spontaneous fusion between MDA-MB-231 variants. Proc. Natl. Acad. Sci. USA 106, 9385\u20139390 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnbt3506_CR29","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/nature03799","volume":"436","author":"AJ Minn","year":"2005","unstructured":"Minn, A.J. et al. Genes that mediate breast cancer metastasis to lung. Nature 436, 518\u2013524 (2005).","journal-title":"Nature"},{"key":"BFnbt3506_CR30","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.jconrel.2014.08.020","volume":"194","author":"KI McConnell","year":"2014","unstructured":"McConnell, K.I. et al. Enhanced gene delivery in porcine vasculature tissue following incorporation of adeno-associated virus nanoparticles into porous silicon microparticles. J. Control. Release 194, 113\u2013121 (2014).","journal-title":"J. Control. Release"}],"container-title":["Nature Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nbt.3506.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nbt.3506","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nbt.3506.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T14:33:22Z","timestamp":1684420402000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nbt.3506"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,14]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["BFnbt3506"],"URL":"https:\/\/doi.org\/10.1038\/nbt.3506","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726216350.793531612","asserted-by":"object"}]},"ISSN":["1087-0156","1546-1696"],"issn-type":[{"value":"1087-0156","type":"print"},{"value":"1546-1696","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,14]]},"assertion":[{"value":"31 March 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}